Compound Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.1K Buy
+100
New +$48K 1.24% 25
2024
Q1
Sell
-11,053
Closed -$5.87M 46
2023
Q4
$5.87M Sell
11,053
-2,937
-21% -$1.42M 1.09% 34
2023
Q3
$7.08M Sell
13,990
-7,936
-36% -$4.23M 1.55% 28
2023
Q2
$11.4M Buy
21,926
+7,639
+53% +$4.12M 2.64% 16
2023
Q1
$8.23M Hold
14,287
2.09% 23
2022
Q4
$7.87M Buy
+14,287
New +$7.57M 2.24% 22

Other funds holding TMO

Compound Global Advisors's TMO Position: Q2 2026 in Review

Compound Global Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 100 shares worth $50.1K. The stake represents 1.24% of the portfolio and ranks #25 among its holdings. This is a return to the name: Compound Global Advisors previously reported a position in TMO as recently as Q4 2023.

Compound Global Advisors first reported a position in TMO in Q4 2022 and has held it in 6 quarters since. The position peaked at $11.4M in Q2 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Compound Global Advisors held 100 shares of Thermo Fisher Scientific worth $50.1K as of Q2 2026.
  • Thermo Fisher Scientific was a new Compound Global Advisors position in Q2 2026.
  • Thermo Fisher Scientific made up 1.24% of Compound Global Advisors's portfolio in Q2 2026, its #25 holding.
  • Compound Global Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 6 quarters since.
  • Compound Global Advisors's Thermo Fisher Scientific position peaked at $11.4M in Q2 2023.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Compound Global Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.